Pfizer CEO Albert Bourla said there are "opportunities that probably outweigh the risks" of the Trump administration's ...

Pfizer CEO Albert Bourla told investors he dined with RFK Jr, a vaccine skeptic and nominee to head HHS. They discussed ...

Investors have been cool to Pfizer, with shares down some 50% since record highs in 2021. Pfizer Chief Executive Albert Bourla has been looking to turn around the company's performance, taking steps ...

Pfizer's fourth quarter beat expectations on strong sales of its Covid vaccine and pill, bolstering its sales as it seeks to ...

In 2021, a series of significant deals were signed ... More recently, Fortune reported Albert Bourla, CEO of Pfizer, as stating that he had high hopes for collaboration with Chinese biotechs ...

In an interview on CNBC’s Mad Money, Dr. Albert Bourla said Pfizer (PFE) is focusing on business development to create shareholder value. “We ...

The pharmaceutical giant named Jeffrey Legos the head of a division it is counting on to overcome investor pressure and grow ...

Elon Musk’s Department of Government Efficiency is here, and defense contractors can’t wait for the “revolution” to reach the ...

Big Pharma is downplaying — for now — the potential negative impacts of President Donald Trump’s China tariffs on their ...

FEATURE PayPal easily beat quarterly estimates for earnings and sales and issued solid guidance, but it wasn’t enough to boost the stock. For its fourth quarter, the fintech reported adjusted earnings ...

Activist investor Starboard Value has launched a broadside against Pfizer's leadership under chief executive Albert Bourla, claiming at least $20 billion in value – and possibly as much as $60 ...